How to use this guide without mistaking it for an exam

What to ask when a claim sounds too neat

Ask whether people felt less sore, moved more easily, or grew cartilage back. Those aren't the same results. A scan may look unchanged even when someone feels better. Care tested on one small cartilage hole may work differently when wear covers much of a knee.

Plain limits matter more than fine words.

Be careful when everyone seems to qualify or success sounds certain. Nothing works for every joint. Ask about cost, risks, follow-up, and reasons the care may not suit you. Then take those answers to your regular doctor. You aren't being difficult—you're protecting your time and money.

When to stop reading and arrange an exam

A clinician needs to see a hot, swollen joint and test new weakness. An exam also matters when the joint locks, gives way, or blocks basic daily tasks. Fever, sudden numbness, or being unable to bear weight calls for prompt care, not more reading.

Your sore joint needs the final word.

For steady soreness, QC Kinetix medical providers—the people who test your movement in Peoria—can discuss regenerative treatment, meaning non-surgical care using body material, including PRP, or platelet-rich plasma: some blood is spun so its clotting parts sit in less fluid, then that fluid is put into the joint to help how it feels or moves, although it won't rebuild a worn joint or help everyone.

Sources

1. Semi-structured interviews with 25 academic specialists - cardiology, ophthalmology, ORTHOPEDICS, pulmonology and neurology - on how they counsel patients asking about experimental stem cell and regenerative interventions. Orthopedists relied most heavily on informational approaches: explaining the science, sharing risks, providing principles. Reported challenges included wanting to support a patient's decision while worrying about harms, and addressing stem cell hype and unrealistic expectations.

   Smith C, et al. — Academic Physician Specialists' Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies-A Qualitative Analysis.. Mayo Clinic proceedings, 2021. DOI: 10.1016/j.mayocp.2021.06.026.

2. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

3. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

4. A randomized, double-blind, placebo-controlled trial in a Japanese population tested leukocyte-POOR PRP specifically in mild-to-moderate knee OA WITH joint effusion or bone marrow lesions - i.e. a selected inflammatory phenotype rather than all comers. Recorded here because phenotype selection, not the product, is the most plausible explanation for why PRP trials disagree with one another.

   Yoshioka T, et al. — The Effectiveness of Leukocyte-Poor Platelet-Rich Plasma Injections for Symptomatic Mild to Moderate Osteoarthritis of the Knee With Joint Effusion or Bone Marrow Lesions in a Japanese Population: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. The American journal of sports medicine, 2024. DOI: 10.1177/03635465241263073.

5. A systematic review of the discordance between clinical and radiographic knee osteoarthritis: many people with severe-looking x-rays have little pain, and many with disabling pain have modest radiographic change. This is the reason a post-treatment scan is a poor proxy for how someone feels, in either direction.

   Bedson J, et al. — The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature.. BMC musculoskeletal disorders, 2008. DOI: 10.1186/1471-2474-9-116.